SPRO · Spero Therapeutics, Inc. · Documents
Market Cap
$64.64M
Shares
58.23M
Volume · Oct 23
316.55K
Avg daily vol (3M)
825.88K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-01-19 | 2021-01-15 | |
| 8-K | — | 2020-12-17 | 2020-12-09 | |
| 8-K | — | 2020-12-03 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 8-K | — | 2020-10-28 | 2020-10-27 | |
| DEF 14A | — | 2020-09-30 | 2020-10-27 | |
| 8-K | — | 2020-09-16 | — | |
| 8-K | — | 2020-09-14 | 2020-09-10 | |
| 8-K | — | 2020-09-09 | — | |
| 8-K | — | 2020-09-08 | — | |
| 8-K | — | 2020-08-06 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-06-04 | — | |
| 8-K/A | — | 2020-05-11 | 2020-04-16 | |
| 8-K | — | 2020-05-08 | — | |
| 10-Q | — | 2020-05-08 | 2020-03-31 | |
| 8-K | — | 2020-04-16 | — | |
| 8-K | — | 2020-03-16 | — | |
| 10-K | — | 2020-03-16 | 2019-12-31 | |
| 8-K | — | 2020-02-28 | — | |
| 8-K | — | 2020-02-11 | — | |
| 8-K | — | 2020-01-30 | — |
Showing 101–123 of 123 filings